S2 Ep 7 Oriana Papin-Zoghbi Co founder & CEO AOA Diagnostics

If women’s health is important to you – don’t miss thisweeks She Leads Biotech!Did you know that:In 2025 it’s estimated that almost 21,000women in the US will receive a new diagnosis of ovarian cancer.A woman’s risk of developing ovarian cancer during her lifetime is about 1-91Appx half the women  diagnosed with ovarian cancer are 63 years or olderAnd there’s no standard screening available for early detection!That’s why I’m so thrilled to have as my guest this week Oriana Papin Zoghbi, CEO of AOA Diagnostics—a company pioneering early detection solutions for ovarian cancer.Ovarian cancer has long been called the "silentkiller", but Oriana and her team are working to change that. She has raised nearly $30 million in funding, built a world-class team, and is breaking new ground in diagnostics. In this episode, Oriana gets candid about:💡 The challenges of leading a startup in healthcare innovation💡 Why failure isn’t the end—it’s part of growth💡 The importance of hiring smart, adaptable people💡 Why investment in diagnostics is critical for saving lives💡 Her vision for the future of women’s health beyond ovarian cancerChapters00:00Introduction and Background01:48Journey into Women's Health Diagnostics04:20Focus on Ovarian Cancer Detection08:22Company Growth and Team Dynamics10:16Leadership and Company Culture23:41Advice for Aspiring CEOs25:23Embracing Failure as a Learning Tool28:40Future Aspirations and Diversification